Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. BioElectronics Corporation (BIEL) Message Board

in ref to Bangladesh distributor ... x xxxxx

Message Board Public Reply | Private Reply | Keep | Replies (4)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 8561
(Total Views: 366)
Posted On: 03/25/2022 12:20:49 PM
Posted By: WBeacham
in ref to Bangladesh distributor ...

x xxxxx <xxxxxxxxxx@gmail.com>
10:23 AM (1 hour ago)
to Kelly

In reference to a tweet on 21 Mar 2022 from BIEL the recent order going to Bangladesh is for a Distributor who it says has a contract w/ the military there. So, does the Distributor have a military (gov't) contract for Actipatch specifically? I don't want to be a nitpicker but I think this is a big deal. If so, first of all, congratulations to Team Biel, and why hasn't BIEL announced it yet? I believe this is the first one I have heard of. Thank you for your time.

Kind regards, WBeacham (moniker on InvestorHangout.com)

kwhelan@bielcorp.com
12:01 PM (7 minutes ago)
to me

We aren’t privy to the specific details of their contract. It is our understanding that they supply their military.

Kelly Whelan, President - BioElectronics Corporation
4539 Metropolitan Court
Frederick, MD 21704
301-476-4376 Direct
301-874-4890 Office
www.bielcorp.com

***** ***** ***** ***** ***** ***** ***** *****

To be clear, CEO Kelly has not closed the door on it being specifically for Actipatch. The possibility exists but we don't know. I appreciate the CEO's punctuality and candor in getting back to a mere shareholder. She's busy and she took the time. That means a lot; to me, at least.

I don't know about anybody else but I get the feeling that whatever next week's financials bring there is something brewing vis-a-vis RecoveryRx. Way too many data points. Lots of emphasis on RRx being 'prescription only'. In my mind I equate 'prescription only' with insurance, but that's me, I guess. I believe the future is dynamic and will be shown to be hugely expansive.

later, WBeacham



(1)
(0)




BioElectronics Corporation (BIEL) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us